Last reviewed · How we verify
Placebo three times daily
This drug has no known mechanism of action.
At a glance
| Generic name | Placebo three times daily |
|---|---|
| Sponsor | Pfizer |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, it does not contain any active pharmaceutical ingredient and therefore does not have a known mechanism of action.
Approved indications
Common side effects
Key clinical trials
- The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. (NA)
- Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis (PHASE1, PHASE2)
- Effects of 2-Aticyto Complex and D-Ribose on Pain and Clinical Course in Patients With Fibromyalgia (NA)
- Extended Oral Tranexamic Acid After Primary Total Knee Arthroplasty (NA)
- Sublingual Cannabidiol for Anxiety (PHASE2)
- A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy (PHASE2, PHASE3)
- Pulsed Electro-Magnetic Field Therapy for Treatment of Midportion Achilles Tendinopathy (NA)
- Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo three times daily CI brief — competitive landscape report
- Placebo three times daily updates RSS · CI watch RSS
- Pfizer portfolio CI